Galectin-3 Predicts Long-Term Risk of Cerebral Disability and Mortality in Out-of-Hospital Cardiac Arrest Survivors
Galectin-3 is a significant, independent long-term risk predictor of cerebral disability and mortality in OHCA survivors. Incorporating galectin-3 into current risk stratification models may enhance early prognostication and guide targeted clinical interventions.
Authors
- Umesh C. Sharma (ORCID: https://orcid.org/0000-0003-0476-2523)
- Sharma Kattel (ORCID: https://orcid.org/0000-0002-9088-2654)
- Arezou Tajlil (ORCID: https://orcid.org/0000-0003-1153-3390)
- Zaid Al-Jebaje (ORCID: https://orcid.org/0000-0002-0699-9340)
- Amr Abdelradi (ORCID: https://orcid.org/0000-0001-6902-675X)
- Wasim Mosleh
- Saraswati Pokharel (ORCID: https://orcid.org/0000-0002-4104-462X)
Institutions
- Roswell Park Comprehensive Cancer Center (US)
- University of Minnesota (US)
- Henry Ford Health System (US)
- University at Buffalo, State University of New York (US)
Publication Details
- Journal
- Journal of Personalized Medicine
- Published
- 2024-09-19
- DOI
- https://doi.org/10.3390/jpm14090994
- Citations
- 1
- Primary Topic
- Cardiac Arrest and Resuscitation
- Type
- article
- Field-Weighted Citation Impact
- 0.69
Funders
- National Heart, Lung, and Blood Institute